CB
Cytek Biosciences Inc
🇺🇸XNAS.CTKBUnited StatesHealthcare
$4.92USDup +0.09 (+1.86%)ClosedEnd of day8:57 PM
Price$4.92+0.09 (+1.86%)
Profile
- Healthcare
- Medical Devices
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US23285D1090
- CUSIP
- 23285D109
Company
- Employees
- 682
- Headquarters
- Fremont, United States
- Website
- https://cytekbio.com
- CEO
- Dr. Wenbin Jiang Ph.D.
Market
- Shares outstanding
- 130M
- Market cap
- $639.52M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $639.52M
- EPS LTM
- -$0.62
- P/E LTM
- -7.12
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $206.71M+5.44%up year on year
- Net income
- -$80.58M-1,158.83%down year on year
- Gross margin
- 53.23%-2.19%down year on year
- Free cash flow
- -$12.08M-209.18%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.